Alcalá PD, Franco CA, Morales E, Cancela R

Language: Spanish
References: 22
Page: 28-34
PDF size: 185.01 Kb.

ABSTRACT

Porphyrias are a group of inherited or acquired disorders that result from partial deficiency in activities of the enzymes of the Hem biosynthetic pathway. Each porphyria is associated with a specific defective enzyme. Porphyria cutanea tarda (PCT) is the only porphyria with both familial and acquired forms, it is caused by a deficiency of the activity of the enzyme uroporphyrinogen descarboxylase and present tipically in adults both occasionally in children, it appears mainly like photosensibility reactions. Recently it has been associated with HIV infection. We report a case of a male patient with PCT and AIDS.

REFERENCES

1. Murray R, Mayes P, Granner D. Bioquímica de Harper 11ª. edición, Manual moderno. México 1988

2. Fitzpatrick T, Woff K, Eisen A et al In: Dermatology in general medicine. 4ª. Edición. Editorial Mc Graw-Hill 1993; 1104-112

3. Arenas R. Dermatología atlas, diagnóstico y tratamiento. McGraw-Hill, México 1987.

4. 4 Amado S. Lecciones de Dermatología.

5. Pawlotsky M, Dhumeaux D, Bagot M. Hepatitis C virus in dermatology. Arch Dermatol 1995; 131: 1185-1193.

6. Cribier B, Petiau P, Keller F. Porphyria cutanea tarda and hepatitis C viral infection. Arch Dermatol 1995; 131: 801-804.

7. Connor O, Murphy G, Fogarty J. Porphyrin abnormalities in acquired immunodeficiency syndrome. Arch Dermatol 1996; 132(12): 1443-7.

8. Lim H. Role of viral infection in porphyria cutanea tarda. Photodermatol-Photoimmunol-Photomed. l997; 13(3): 75-7.

9. Casanova J, Pérez J, Cuadrat M. Porfiria cútanea tarda en 2 pacientes VIH y VHC-positivos. Piel 1996; 11: 185-8.

10. Carrera L, Varela J, Avila F. Porfiria cutánea tarda asociada a virus de la hepatitis C. Arch Argent Dermatol 1995; 45: 213-7.

11. Blauvelt A. Hepatitis C virus and human immunodeficiency virus infection can alter porphyrin metabolism and lead to porphyria cutanea tarda. Arch Dermatol 1996; 132(12): 1503-4.

12. Blauvelt A, Harris R,. Hogan D. Porphyria cutanea tarda and human immunodeficiency virus infection. International Dermatol 1992; 31: 474-9.

13. Wissel PS, Soordillo P, Andersen KE. Porphyria cutanea tarda associated with the acquired immunodeficiency syndrome. Am J Hematol 1987; 25: 107-113.

14. Lafevillade A, Dhiver M, Qhihehini R. Porphyria cutanea tarda associated with HIV infection. AIDS 1990; 4: 924.

15. Fuch D, Artner-Dworzak E, Hanse A. Urinary excretion at porphyrines in increased in patients with HIV-1 infection 1990; 4: 341-4.

16. Reynaud P, Goodfellow K, Svec F. Porphyria cutanea tarda as initial presentation of the acquired immunodeficiency syndrome in two patients. J Infect Dis 1991; 161: 1032-3.

17. Hoegl L, Greber T, Rocken M. Porphyria cutanea type 1 in HIV infection. Hautarzt 1996; 47(1) 58-61.

18. Pascual C, García P, Bartralot R. Cutaneous pigmentation, only manifestation of porphyria cutanea tarda in a HIV-1 positive patient. Ann Dermatol Venereol 1996; 123(4): 262-4.

19. Fuchs D, Baier G, Wachter H. Human immunodeficiency virus infection and porphyria cutanea tarda. Clin Infect Dis 1995; 21(6): 1530-1.

20. Kemper W. Porphyria cutanea tarda associated with human immunodeficiency virus infection. Clin infect Dis 1995; 21(6): 1530.

21. McAlister F, McClean K, Hamilton PG. Human immunodeficiency virus infection and porphyria cutanea tarda: coexistence of risk factors or causative association?. Clin Infect Dis 1995; 20(2): 348-51.

22. Sepkowitz DV, Hennessey P, Torno RB. Hepatic manifestations of porphyria cutanea tarda in a patient with AIDS. Am J Gastroenterol 1995; 90(4): 658-9.